Paweł Mróz

12.3k total citations · 3 hit papers
59 papers, 10.1k citations indexed

About

Paweł Mróz is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Immunology. According to data from OpenAlex, Paweł Mróz has authored 59 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 39 papers in Biomedical Engineering and 11 papers in Immunology. Recurrent topics in Paweł Mróz's work include Photodynamic Therapy Research Studies (40 papers), Nanoplatforms for cancer theranostics (38 papers) and Immunotherapy and Immune Responses (11 papers). Paweł Mróz is often cited by papers focused on Photodynamic Therapy Research Studies (40 papers), Nanoplatforms for cancer theranostics (38 papers) and Immunotherapy and Immune Responses (11 papers). Paweł Mróz collaborates with scholars based in United States, Poland and Japan. Paweł Mróz's co-authors include Michael R. Hamblin, Ana P. Castaño, Jakub Gołąb, Dominika Nowis, Johan Moan, Patrizia Agostinis, Jacques Piette, Sandra O. Gollnick, Mladen Korbelik and Stephen M. Hahn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Paweł Mróz

57 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Photodynamic therapy of cancer: An update

2011 4.3k citations Patrizia Agostinis, Kristian Berg et al. CA A Cancer Journal for Clinicians profile →
Photodynamic therapy and anti-tumour immunity

2006 2.3k citations Ana P. Castaño, Paweł Mróz et al. Nature reviews. Cancer profile →
Cell Death Pathways in Photodynamic Therapy of Cancer

2011 554 citations Paweł Mróz, Michael R. Hamblin et al. profile →

Peers

Countries citing papers authored by Paweł Mróz

Since Specialization

Citations

This map shows the geographic impact of Paweł Mróz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Mróz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Mróz more than expected).

Fields of papers citing papers by Paweł Mróz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paweł Mróz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Mróz. The network helps show where Paweł Mróz may publish in the future.

Co-authorship network of co-authors of Paweł Mróz

This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Mróz. A scholar is included among the top collaborators of Paweł Mróz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Mróz. Paweł Mróz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real‐World Characterization of Psychiatric Pharmacogenomic Test Ordering and Clinical Relevance in Adults and Children 2025 ·Clinical and Translational Science ·(unknown), (unknown), Kevin Jones, (unknown), (unknown), Kathryn R. Cullen, Meredith Gunlicks‐Stoessel, Paweł Mróz, Joel F. Farley, Steve Johnson, Jeffrey R. Bishop	0
2	Validation of a comprehensive long-read sequencing platform for broad clinical genetic diagnosis 2025 ·Frontiers in Genetics ·Siddhartha Sen, (unknown), Alec Victorsen, (unknown), (unknown), Todd P. Knutson, Sarah Munro, Ryan J. Martinez, Charles J. Billington, Jennifer Laffin, Sarah Bray, Paweł Mróz, Sophia Yohe, Andrew C. Nelson, Matthew Bower, Bharat Thyagarajan	1
3	Assessing acquired resistance to IDH1 inhibitor therapy by full-exon IDH1 sequencing and structural modeling 2021 ·Molecular Case Studies ·Zoltán N. Oltvai, (unknown), David Ryan Koes, (unknown), Erica D. Warlick, Andrew C. Nelson, Sophia Yohe, Paweł Mróz	18
4	A Rare Complication of Thymoma: Pure White Cell Aplasia in Good’s Syndrome 2019 ·SHILAP Revista de lepidopterología ·(unknown), Elizabeth Levin, Paweł Mróz, Faqian Li, Surbhi Shah	7
5	CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer 2013 ·Journal of Biophotonics ·Yumin Xia, Gaurav K. Gupta, Ana P. Castaño, Paweł Mróz, Pinar Avci, Michael R. Hamblin	52
6	Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle 2012 ·Journal of Controlled Release ·María García-Díaz, (unknown), Paweł Mróz, M. Lluïsa Sagristá, Margarita Mora, Santi Nonell, Michael R. Hamblin	30
7	Photodynamic Therapy for Cancer and for Infections: What Is the Difference? 2012 ·Israel Journal of Chemistry ·Sulbha K. Sharma, Paweł Mróz, Tianhong Dai, Ying‐Ying Huang, Tyler G. St. Denis, Michael R. Hamblin	80
8	Photodynamic therapy of cancer: An update breakdown → 2011 ·CA A Cancer Journal for Clinicians ·Patrizia Agostinis, Kristian Berg, Keith A. Cengel, Thomas H. Foster, Albert W. Girotti, Sandra O. Gollnick, Stephen M. Hahn, Michael R. Hamblin, Asta Juzeniene, David Kessel, Mladen Korbelik, Johan Moan, Paweł Mróz, Dominika Nowis, Jacques Piette, Brian C. Wilson, Jakub Gołąb	4317
9	The immunosuppressive side of PDT 2011 ·Photochemical & Photobiological Sciences ·Paweł Mróz, Michael R. Hamblin	75
10	Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma 2011 ·Nanomedicine Nanotechnology Biology and Medicine ·Paweł Mróz, Yumin Xia, Daisuke Asanuma, (unknown), Timur Zhiyentayev, Ying‐Ying Huang, Sulbha K. Sharma, Tianhong Dai, (unknown), Tim Wharton, Michael R. Hamblin	51
11	Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response 2010 ·PLoS ONE ·Paweł Mróz, Angelika Szokalska, Mei X. Wu, Michael R. Hamblin	117
12	Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models 2010 ·Journal of Biomedical Optics ·Jesung Park, Paweł Mróz, Michael R. Hamblin, Anna N. Yaroslavsky	17
13	In Vitro Photodynamic Therapy and Quantitative Structure−Activity Relationship Studies with Stable Synthetic Near-Infrared-Absorbing Bacteriochlorin Photosensitizers 2010 ·Journal of Medicinal Chemistry ·Ying‐Ying Huang, Paweł Mróz, Timur Zhiyentayev, Sulbha K. Sharma, Thiagarajan Balasubramanian, Christian Ruzié, Michael Krayer, Dazhong Fan, K. Eszter Borbas, Eunkyung Yang, Hooi Ling Kee, Christine Kirmaier, James R. Diers, David F. Bocian, Dewey Holten, Jonathan S. Lindsey, Michael R. Hamblin	84
14	Stimulation of anti-tumor immunity by photodynamic therapy 2010 ·Expert Review of Clinical Immunology ·Paweł Mróz, Javad T. Hashmi, Ying‐Ying Huang, Norbert Lange, Michael R. Hamblin	209
15	Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: Role of molecular charge, central metal and hydroxyl radical production 2009 ·Cancer Letters ·Paweł Mróz, Jayeeta Bhaumik, Dilek K. Dogutan, Zarmeneh Aly, (unknown), Laiqua Khalid, Hooi Ling Kee, David F. Bocian, Dewey Holten, Jonathan S. Lindsey, Michael R. Hamblin	109
16	Photophysical characterization of imidazolium-substituted Pd(II), In(III), and Zn(II) porphyrins as photosensitizers for photodynamic therapy 2008 ·Journal of Photochemistry and Photobiology A Chemistry ·Hooi Ling Kee, Jayeeta Bhaumik, James R. Diers, Paweł Mróz, Michael R. Hamblin, David F. Bocian, Jonathan S. Lindsey, Dewey Holten	96
17	Photodynamic therapy with fullerenes 2007 ·Photochemical & Photobiological Sciences ·Paweł Mróz, George P. Tegos, Hariprasad Gali, Tim Wharton, Tadeusz Sarna, Michael R. Hamblin	238
18	Photodynamic therapy and anti-tumour immunity breakdown → 2006 ·Nature reviews. Cancer ·Ana P. Castaño, Paweł Mróz, Michael R. Hamblin	2285
19	Mechanizmy indukcji apoptozy i zastosowanie TRAIL w terapii nowotworow. 2003 ·Postepy Biologii Komorki ·Paweł Mróz, Izabela Młynarczuk-Biały	2
20	AAF-cmk sensitizes tumor cells to trail-mediated apoptosis 2003 ·Leukemia Research ·(unknown), Paweł Mróz, Grażyna Hoser, Dominika Nowis, Łukasz P. Biały, (unknown), Tomasz Grzela, Wojciech Feleszko, Jacek Malejczyk, Cezary Wójcik, Marek Jakóbisiak, Jakub Gołąb	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact